An international team of researchers, led by scientists at The Institute of Cancer Research, London, are planning to trial a novel saliva-based DNA test designed to predict men at risk of developing prostate cancer.
12th June 2018
The University of Huddersfield has launched the Centre for Pharmaceutical Policy and Practice Research, tasked with keeping the industry “armed with the latest research methods and advice”.
11th June 2018
AstraZeneca’s Tagrisso has been given a green light in Europe for first-line use to treat EGFR-mutated non-small cell lung cancer (NSCLC), offering a new line of attack at this stage of the disease.
11th June 2018
US regulators have approved a combination of AbbVie and Roche’s Venclexta in combination with Roche/Biogen's Rituxan (rituximab) to treat chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL).
11th June 2018
Vertex has presented long-term, observational data highlighting the benefit of Kalydeco in patients with cystic fibrosis.
8th June 2018
Following on from Dr Jim Golby’s comments only last week, David Garmon-Jones, co-chair of the competition’s executive steering group (ESG) is also calling on all pharma sales professionals to get involved in the competition.
8th June 2018
With spaces in the Communications Team of the Year competition filling up fast, agencies are advised to act now and get their entry for the NHS Challenge in before it's too late!
8th June 2018
Roche group Genentech has received US approval for Rituxan to treat moderate to severe pemphigus vulgaris (PV), giving patients access to the first new therapy for the condition in more than 60 years.
8th June 2018
Regulators on both sides of the Atlantic have accepted for review Pfizer’s PARP inhibitor talazoparib as a treatment for women with a hereditary BRCA mutation.
8th June 2018
The Competition Appeal Tribunal in the UK has overturned a £90 million fine for Pfizer and Flynn Pharma issued by the Competition and Markets Authority for charging unfair prices for phenytoin sodium capsules.
8th June 2018
Boehringer Ingelheim’s Spiriva Respimat is now licensed for use in the UK to treat people with asthma aged six years and older.
7th June 2018
The High Court has rejected a legal challenge by the British Homeopathy Association to block plans to no longer routinely fund homeopathy on the NHS.
7th June 2018
The amount the UK spends on health falls well behind that invested by European peers such as Germany and France, according to a report commissioned by the NHS Confederation
7th June 2018
MSD’s Keytruda will be routinely available on the NHS for specific patients with previously untreated metastatic non-small-cell lung cancer, after NHS England struck a deal with the company, endorsed by NICE, to ensure its cost-effectiveness.
7th June 2018
Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.
7th June 2018
